邢晓娜

【摘要】目的：探讨分析对高血压患者采用厄贝沙坦联合美托洛尔进行治疗的临床应用效果。方法：本次研究对象均选自我院2017年12月到2019年12月期间收治的高血压患者共180例，设定其中90例患者为单一用药组并采用单一厄贝沙坦治疗，其余90例患者作为联合用药组则是在前者基础上联合美托洛尔进行治疗，比较两组患者的治疗效果。结果：比较两组患者的治疗效果、血压控制效果以及不良反应发生率，联合用药组均优于单一用药组（P<0.05）。结论：根据本次研究的结果可以确认，对高血压患者采用厄贝沙坦联合美托洛尔进行治疗有着令人满意的效果，不仅能够有效控制患者的血压，还不会引发患者出现严重不良反应，具有临床推广价值。

【关键词】高血压;厄贝沙坦;美托洛尔;治疗效果;对比分析

【中图分类号】R544.1 【文献标识码】A

[Abstract] Objective：To investigate and analyze the clinical effect of irbesartan combined with metoprolol in the treatment of hypertension. Methods：a total of 180 patients with hypertension admitted to our hospital from December 2017 to December 2019 were selected in this study. Among them， 90 patients were selected as the single drug group and treated with single irbesartan， while the other 90 patients as the combined drug group were treated with metoprolol on the basis of the former. The therapeutic effects of the two groups were compared. Results：compared the treatment effect， blood pressure control effect and incidence of adverse reactions between the two groups， the combination group was better than the single drug group （P < 0.05）. Conclusion：according to the results of this study， irbesartan combined with metoprolol in the treatment of patients with hypertension has a satisfactory effect， not only can effectively control the patient's blood pressure， but also will not cause serious adverse reactions in patients， with clinical promotion value.

[Key words] hypertension; irbesartan; metoprolol; therapeutic effect; comparative analysis

高血压作为一种临床上比较常见的慢性疾病，如果患者没有接受及时有效的治疗，不仅会对患者的重要脏器带来极大的损伤，还会导致患者发生血管疾病的概率大幅提高。针对高血压疾病，采用药物治疗有着很好的效果，通过给予患者降压药物，能够将患者的血压控制在正常的范围内。目前在临床上对高血压应用最为广泛的药物就是厄贝沙坦以及美托洛尔，但是如果只是对患者使用单一某一种药物进行治疗的效果却并不是很好，而通过将两种药物联合对患者使用，则能够有效提高对患者的治疗效果[1]。……